Facebook Pixel Disclosure, but still no aliens | Business Standard - newspaper - Lisez cet article sur Magzter.com

Essayer OR - Gratuit

Disclosure, but still no aliens

Business Standard

|

November 29, 2025

The Age of Disclosure arrives during a period of acute public interest in unidentified anomalous phenomena (UAPs), met by predictably cautious official pronouncements.

- KUMAR ABISHEK

Director Dan Farah, steeped in the cinematic mythology of E.T. and The X-Files from his growing up years in the 80s and ‘90s, presents his documentary not as conspiratorial froth but as a compilation of testimony from insiders who suggest the United States has quietly accumulated decades of information, and potentially material, suggesting nonhuman intelligence.

Mr Farah has stacked his cast with serious operators. The documentary pulls in 34 contributors, a mix of Congressional figures and longtime national security officers whose job descriptions usually keep them far from speculation. ‘Their presence gives the film an air of institutional weight that conspiracy fare normally lacks.

Jay Stratton, former director of the Pentagon's UAP Task Force, appears on camera to declare that he has seen with his eyes “nonhuman craft and nonhuman beings”. Eric Davis recalls the Soviet recovery of humanoid bodies in 1989. And Marco Rubio, US Secretary of State, warns that UAP intelligence is so tightly compartmentalised that “much of it is restricted even from presidents.”

In an era where every minor mishap is filmed in high definition grainy UFO videos have lost their sting. But those with decades of top-level security clearances are considerably harder to dismiss.

PLUS D'HISTOIRES DE Business Standard

Business Standard

Nalco urges Odisha govt to expedite land handover process for ‘30K cr projects

Navratna central public-sector enterprise (CPSE) Nalco has requested the Odisha government to expedite the land handover process for its 30,000 crore expansion projects that will boost capacity and help it achieve the Maharatna status by 2030.

time to read

1 mins

March 10, 2026

Business Standard

Women-led startups saw 9% funding drop in 2025

Female labour participation just 42%, among lowest in G20: Axis Bank study

time to read

3 mins

March 10, 2026

Business Standard

Business Standard

How India can kick the West Asian oil habit

Increasing the use of alternative fuels like ethanol could be one way out

time to read

6 mins

March 10, 2026

Business Standard

India’s T20 WC win brings new stars to brand crease

\"Sachin Tendulkar carried Indian cricket on his shoulders for 21 years.

time to read

3 mins

March 10, 2026

Business Standard

UBS downgrades OMCs as oil crosses $100/bbl

The recent rally in crude prices and refining margins create a sense of déjà vu, UBS said, mirroring the 2022 oil market disruption.

time to read

1 min

March 10, 2026

Business Standard

LIC drove 18% rise in life insurers’ NBP in Feb

New business premium of life insurance companies grew 18 per cent year-on-year (Y-o-Y) to ₹35,417 crore in February, driven by robust growth at the state-owned Life Insurance Corporation of India (LIC) due to a favourable base.

time to read

1 mins

March 10, 2026

Business Standard

Why India needs Russian oil

India's oil security is becoming increasingly fragile. Over 80 per cent of its crude imports come from just two suppliers — West Asia and Russia — both now facing geopolitical stress. In this environment, resuming full purchases of Russian oil may not be a choice but a necessity. Here are eight reasons why.

time to read

3 mins

March 10, 2026

Business Standard

India, Uzbekistan launch pharma-nutra corridor

India and Uzbekistan on Monday launched a structured pharmaceutical and nutraceutical trade corridor aimed at expanding access to the Commonwealth of Independent States (CIS) and the wider Eurasian healthcare market, estimated at $7-10 billion.

time to read

1 min

March 10, 2026

Business Standard

Business Standard

A clear derating

Markets risk underperformance if we don’t regain our growth credentials

time to read

5 mins

March 10, 2026

Business Standard

Delhi HC allows Dr Reddy’s to make semaglutide for export

A division Bench of the Delhi High Court on Monday affirmed a single-judge Bench’s order allowing pharmaceutical company Dr Reddy’s Laboratories to manufacture the diabetes and weight-management drug semaglutide in India for export to jurisdictions where Danish drugmaker Novo Nordisk does not have patent protection.

time to read

2 mins

March 10, 2026

Listen

Translate

Share

-
+

Change font size